BNP Paribas Financial Markets’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-134
| Closed | -$114 | – | 5853 |
|
|
2025
Q4 | $114 | Hold |
134
| – | – | ﹤0.01% | 5602 |
|
|
2025
Q3 | $222 | Hold |
134
| – | – | ﹤0.01% | 5384 |
|
|
2025
Q2 | $158 | Hold |
134
| – | – | ﹤0.01% | 5300 |
|
|
2025
Q1 | $289 | Hold |
134
| – | – | ﹤0.01% | 5184 |
|
|
2024
Q4 | $379 | Buy |
+134
| New | +$636 | ﹤0.01% | 5197 |
|
|
2022
Q4 | – | Sell |
-134
| Closed | -$348 | – | 4138 |
|
|
2022
Q3 | $348 | Buy |
+134
| New | +$431 | ﹤0.01% | 4556 |
|
|
2022
Q2 | – | Sell |
-135
| Closed | -$1.09K | – | 4103 |
|
|
2022
Q1 | $1.09K | Hold |
135
| – | – | ﹤0.01% | 3951 |
|
|
2021
Q4 | $1.08K | Sell |
135
-51
| -27% | -$508 | ﹤0.01% | 4049 |
|
|
2021
Q3 | $2.21K | Hold |
186
| – | – | ﹤0.01% | 3787 |
|
|
2021
Q2 | $2.88K | Sell |
186
-642
| -78% | -$10.8K | ﹤0.01% | 3843 |
|
|
2021
Q1 | $19.9K | Sell |
828
-281
| -25% | -$7.89K | ﹤0.01% | 3761 |
|
|
2020
Q4 | $32.7K | Sell |
1,109
-385
| -26% | -$8.37K | ﹤0.01% | 3724 |
|
|
2020
Q3 | $22.9K | Buy |
1,494
+1,069
| +252% | +$20.1K | ﹤0.01% | 3785 |
|
|
2020
Q2 | $10.6K | Sell |
425
-1,122
| -73% | -$24.4K | ﹤0.01% | 3682 |
|
|
2020
Q1 | $31.6K | Buy |
1,547
+814
| +111% | +$19.4K | ﹤0.01% | 3759 |
|
|
2019
Q4 | $22.7K | Sell |
733
-67
| -8% | -$2.17K | ﹤0.01% | 3961 |
|
|
2019
Q3 | $26.7K | Buy |
800
+215
| +37% | +$6.9K | ﹤0.01% | 3818 |
|
|
2019
Q2 | $18.7K | Sell |
585
-452
| -44% | -$14.4K | ﹤0.01% | 3918 |
|
|
2019
Q1 | $29.8K | Buy |
+1,037
| New | +$36.1K | ﹤0.01% | 3777 |
|
|
2018
Q4 | – | Sell |
-163
| Closed | -$7.62K | – | 4338 |
|
|
2018
Q3 | $7.62K | Hold |
163
| – | – | ﹤0.01% | 3874 |
|
|
2018
Q2 | $13.4K | Buy |
+163
| New | +$11K | ﹤0.01% | 3661 |
|
|
2014
Q2 | – | Sell |
-11
| Closed | -$194 | – | 3838 |
|
|
2014
Q1 | $194 | Hold |
11
| – | – | ﹤0.01% | 3218 |
|
|
2013
Q4 | $185 | Buy |
+11
| New | +$186 | ﹤0.01% | 4025 |
|
Other funds holding CASI
BNP Paribas Financial Markets's CASI Position: Q1 2026 in Review
BNP Paribas Financial Markets sold out of CASI Pharmaceuticals (CASI) in Q1 2026, closing a stake of 134 shares — an estimated $114 sold.
BNP Paribas Financial Markets first reported a position in CASI in Q4 2013 and held it in 23 quarters. The position peaked at $32.7K in Q4 2020. 1 fund tracked by Wall St. Rank holds CASI as of Q1 2026.
- BNP Paribas Financial Markets reported no remaining CASI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- BNP Paribas Financial Markets sold 134 CASI Pharmaceuticals shares in Q1 2026, an estimated $114.
- BNP Paribas Financial Markets first reported a position in CASI Pharmaceuticals in Q4 2013 and held it in 23 quarters.
- BNP Paribas Financial Markets's CASI Pharmaceuticals position peaked at $32.7K in Q4 2020.
- 1 fund tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.